Fisher M M, Munro I
Anesth Analg. 1983 Jun;62(6):559-64.
Sixty-seven patients who had life-threatening reactions to muscle relaxant drugs diagnosed by intradermal testing or challenge were studied. Six patients reacted on two occasions; four reacted to different relaxants. There was a significantly greater ratio of female-to-male patients who reacted than in a nonreacting population. Patients who reacted to muscle relaxants had an incidence of allergy, atopy, asthma, and previous reactions to anesthesia that was significantly greater than nonreacting patients, but not greater than patients who had reacted to induction agents. Eighty-five percent of patients who reacted to muscle relaxants had never previously been exposed to the drug, whereas 60% of patients reacting adversely to induction agents had been previously exposed to induction agents. The reactions were not related to additives or preservatives. In spite of a lack of previous exposure, type I hypersensitivity appears the most likely mechanism responsible for life-threatening reactions to muscle relaxants.
对67例经皮内试验或激发试验诊断为对肌肉松弛药物有危及生命反应的患者进行了研究。6例患者有两次反应;4例对不同的松弛剂有反应。有反应的患者中女性与男性的比例显著高于无反应人群。对肌肉松弛剂有反应的患者中,过敏、特应性、哮喘和既往麻醉反应的发生率显著高于无反应患者,但不高于对诱导剂有反应的患者。85%对肌肉松弛剂有反应的患者此前从未接触过该药物,而60%对诱导剂有不良反应的患者此前曾接触过诱导剂。这些反应与添加剂或防腐剂无关。尽管此前未接触过,但I型超敏反应似乎是导致对肌肉松弛剂产生危及生命反应的最可能机制。